Icosavax Financials
Based on the key measurements obtained from Icosavax's financial statements, Icosavax is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
Icosavax |
Understanding current and past Icosavax Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Icosavax's financial statements are interrelated, with each one affecting the others. For example, an increase in Icosavax's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Icosavax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Icosavax. Check Icosavax's Beneish M Score to see the likelihood of Icosavax's management manipulating its earnings.
Icosavax Stock Summary
Icosavax competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, and X4 Pharmaceuticals. Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company was incorporated in 2017 and is headquartered in Seattle, Washington. Icosavax operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US45114M1099 |
Business Address | 1930 Boren Avenue, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | icosavax.com |
Phone | 206 737 0085 |
Currency | USD - US Dollar |
Icosavax Key Financial Ratios
Icosavax Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Icosavax's current stock value. Our valuation model uses many indicators to compare Icosavax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icosavax competition to find correlations between indicators driving Icosavax's intrinsic value. More Info.Icosavax is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Icosavax's earnings, one of the primary drivers of an investment's value.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Stocks Directory Find actively traded stocks across global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Transaction History View history of all your transactions and understand their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |